Ethical guidance for dementia diagnosis, care: AAN
The American Academy of Neurology recently updated its 1996 ethical guidance for dementia. However, the position paper was developed before FDA approval of the new medication aducanumab and does not address that drug. Following are some highlights of the paper.
This is a benefit of membership. If you are not an ICAA member you will need to purchase a membership for access. To learn more here